Journal article
Valacyclovir for herpes simplex encephalitis.
- Abstract:
- The recommended treatment for herpes simplex encephalitis (HSE) remains intravenous acyclovir. In resource-poor countries, however, intravenous formulations are usually unavailable or unaffordable. We report the penetration of acyclovir into the cerebrospinal fluid (CSF) in patients with HSE, treated with the oral prodrug valacyclovir at 1,000 mg three times daily. The oral therapy achieved adequate acyclovir concentrations in the CSF and may be an acceptable early treatment for suspected HSE in resource-limited settings.
- Publication status:
- Published
Actions
Access Document
- Publisher copy:
- 10.1128/aac.01023-10
Authors
- Journal:
- Antimicrobial agents and chemotherapy More from this journal
- Volume:
- 55
- Issue:
- 7
- Pages:
- 3624-3626
- Publication date:
- 2011-07-01
- DOI:
- EISSN:
-
1098-6596
- ISSN:
-
0066-4804
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:140893
- UUID:
-
uuid:1e59adf5-9dd6-4feb-9d02-2424b493e937
- Local pid:
-
pubs:140893
- Source identifiers:
-
140893
- Deposit date:
-
2012-12-19
- ARK identifier:
Terms of use
- Copyright date:
- 2011
If you are the owner of this record, you can report an update to it here: Report update to this record